Top 10 ALS news stories of 2024
Dec 30, 2024 · Read this story here. No. 8 – COYA 302 immune-modulating therapy shows promise in small early trial. Coya Therapeutics’ investigational therapy COYA 302 was found …
Neurosense finalizing protocol for Phase 3 ALS trial of PrimeC
Dec 19, 2024 · In PARADIGM (NCT05357950), a completed Phase 2b study, PrimeC was tested against a placebo, both taken as two tablets by mouth twice daily for six months, in 68 adults …
ALS News Today Home | ALS News Today
6 days ago · Zydus cleared to begin US trial of oral therapy usnoflast for ALS. Zydus Lifesciences has been cleared by the U.S. Food and Drug Administration (FDA) to initiate a Phase 2b trial …
Choosing how to communicate about ALS — and when
Dec 27, 2024 · It took us more than three months to share freely that Jeff had been diagnosed with ALS. Because he had a large network of friends and colleagues around the world, we …
FDA outlines steps to consider accelerated approval of CNM-Au8
Dec 11, 2024 · The therapy’s developer, Clene, said it will put together an application in the coming months, with the goal of submitting it in mid-2025. “We are incredibly grateful for the …
Feeding tube best placed before major weight loss with ALS: Study
Dec 24, 2024 · Findings suggest that feeding tubes placed before substantial weight loss may extend survival for people with ALS, the researchers said. The study, “ Predictors of mortality …
Zydus cleared to begin US trial of oral therapy usnoflast for ALS
5 days ago · Oral therapy aims to block inflammasome. The exact mechanisms that drive the onset and progression of ALS remain poorly understood, but inflammation is thought to …
HEALEY ALS trial to allow longer follow-up, blood cell collection
Dec 20, 2024 · The HEALEY ALS platform trial, which is simultaneously testing multiple potential treatments for amyotrophic lateral sclerosis (ALS), is amending its master protocol to allow a …
News Archives - ALS News Today
New ALS trial data show nearly 2-year survival benefit with NP001. NP001 (sodium chlorite) was associated with a significant survival benefit among a subset of amyotrophic lateral sclerosis …
Healthcare costs increase as ALS progresses, per Biogen US study
Dec 23, 2024 · Due to substantial increases in the use of healthcare resources, medical costs in the U.S. for people with amyotrophic lateral sclerosis (ALS) rise significantly as the disease …